4.4 Article

Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies

期刊

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/jnci/djq526

关键词

-

类别

资金

  1. European Community [223175, HEALTH-F2-2009-223175]
  2. Australian Breast Cancer Family Study (ABCFS)
  3. National Cancer Institute (NCI), National Institutes of Health (NIH) [RFA CA-06-503]
  4. Breast Cancer Family Registry (BCFR)
  5. Cancer Care Ontario [U01 CA69467]
  6. Northern California Cancer Center [U01 CA69417]
  7. University of Melbourne [U01 CA69638]
  8. National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre
  9. Chief Physician Johan Boserup and Lise Boserup Fund
  10. Danish Medical Research Council
  11. Copenhagen University Hospital, Herlev Hospital
  12. Red Tematica de Investigacion Cooperativa en Cancer
  13. Asociacion Espanola Contra Cancer
  14. Fondo de Investigacion Sanitario [PI081120, PI081583]
  15. Federal Ministry of Education and Research (BMBF) Germany [01KW9975/5, 01KW9976/8, 01KW9977/0, 01KW0114]
  16. Robert Bosch Foundation of Medical Research, Stuttgart
  17. Deutsches Krebsforschungszentrum (DKFZ), Heidelberg
  18. Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA), Bochum
  19. Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany
  20. Deutsche Krebshilfe [70492, 70-2892-BR I]
  21. state of Baden-Wurttemberg through the Medical Faculty of the University of Ulm [P. 685]
  22. Helsinki University Central Hospital
  23. Academy of Finland [110663]
  24. Finnish Cancer Society
  25. Sigrid Juselius Foundation
  26. European Union Framework Programme 6 [LSHC-CT-2003-503297]
  27. Stichting tegen Kanker [232-2008]
  28. Swedish Cancer Society
  29. Gustav V Jubilee Foundation
  30. Cancer Society in Stockholm
  31. Bert von Kantzow Foundation
  32. Kuopio University Central EVO
  33. Academy of Finland
  34. University of Kuopio
  35. EVO of Vaasa Hospital District
  36. Kathleen Cuningham Foundation Consortium
  37. NHMRC [145684, 288704, 454508, 209057, 251533, 396414, 504711]
  38. National Breast Cancer Foundation
  39. Queensland Cancer Fund
  40. Cancer Councils of Victoria
  41. Cancer Councils of Tasmania
  42. Cancer Councils of South Australia
  43. Cancer Councils of New South Wales
  44. Cancer Foundation of Western Australia
  45. Hamburg Cancer Society
  46. German Cancer Research Center
  47. NIH [CA122340, ARRA CA122340Z, R01-CA63464, R37-CA54281, CA87969]
  48. NCI [CA116201]
  49. Cancer Council Victoria, VicHealth
  50. Cancer Research UK [11022, 10118] Funding Source: researchfish
  51. National Institute for Health Research [03/DHCS/03/G121/51] Funding Source: researchfish
  52. The Francis Crick Institute
  53. Cancer Research UK [10124] Funding Source: researchfish

向作者/读者索取更多资源

Background Previous studies have suggested that breast cancer risk factors are associated with estrogen receptor (ER) and progesterone receptor (PR) expression status of the tumors. Methods We pooled tumor marker and epidemiological risk factor data from 35 568 invasive breast cancer case patients from 34 studies participating in the Breast Cancer Association Consortium. Logistic regression models were used in case-case analyses to estimate associations between epidemiological risk factors and tumor subtypes, and case-control analyses to estimate associations between epidemiological risk factors and the risk of developing specific tumor subtypes in 12 population-based studies. All statistical tests were two-sided. Results In case-case analyses, of the epidemiological risk factors examined, early age at menarche (<= 12 years) was less frequent in case patients with PR- than PR+ tumors (P = .001). Nulliparity (P = 3 x 10(-6)) and increasing age at first birth (P = 2 x 10(-9)) were less frequent in ER- than in ER+ tumors. Obesity (body mass index [BMI] >= 30 kg/m(2)) in younger women (<= 50 years) was more frequent in ER /PR than in ER+/PR+ tumors (P = 1 x 10(-7)), whereas obesity in older women (>50 years) was less frequent in PR- than in PR+ tumors (P = 6 x 10(-4)). The triple-negative (ER-/PR-/HER2-) or core basal phenotype (CBP; triple-negative and cytokeratins [CK]5/6(+) and/ or epidermal growth factor receptor [EGFR] 1) accounted for much of the heterogeneity in parity-related variables and BMI in younger women. Case-control analyses showed that nulliparity, increasing age at first birth, and obesity in younger women showed the expected associations with the risk of ER+ or PR+ tumors but not triple-negative (nulliparity vs parity, odds ratio [OR] = 0.94, 95% confidence interval [CI] = 0.75 to 1.19, P = .61; 5-year increase in age at first full-term birth, OR = 0.95, 95% CI = 0.86 to 1.05, P = .34; obesity in younger women, OR = 1.36, 95% CI = 0.95 to 1.94, P = .09) or CBP tumors. Conclusions This study shows that reproductive factors and BMI are most clearly associated with hormone receptor-positive tumors and suggest that triple-negative or CBP tumors may have distinct etiology.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据